» Articles » PMID: 24283920

β-Cell Dysfunction is Associated with Metabolic Syndrome Severity in Adults

Overview
Date 2013 Nov 29
PMID 24283920
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metabolic syndrome is prevalent in adults characterized by increased visceral adiposity and insulin resistance (IR). However, the link between pancreatic β-cell function and metabolic syndrome severity in adults across the glucose spectrum is unknown. We hypothesized that poor β-cell function would independently predict a higher metabolic syndrome Z-score (i.e., severity).

Methods: Seventy (12 normal glucose tolerant, 37 prediabetic, 21 type 2 diabetic) obese adults [62.4±1.1 year; 34.6±0.6 kg/m(2); data are mean±standard error of the mean (SEM)] participated in this cross-sectional study. A 2-hr 75-gram oral glucose tolerance test (OGTT) was administered, and insulin and glucose area under the curve was determined for calculations of insulin action. Fasting and glucose-stimulated insulin secretion was calculated using homeostasis model assessment of insulin secretion (HOMA-B) and the insulinogenic index (i.e., I(0-30)/Glc(0-30) or I(60-120)/Glc(60-120)), respectively. Fasting and postprandial insulin sensitivity was assessed by HOMA-IR and the Matsuda Index, respectively. β-cell function was estimated using the disposition index via HOMA-B/HOMA-IR, I(0-30)/Glc(0-30) or I(60-120)/Glc(60-120) × Matsuda Index, which represents basal, first-, and second-phase insulin release, respectively. Body composition (via computerized tomography and dual X-ray absorptiometry) and sex-specific metabolic syndrome Z-scores were calculated from waist circumference, blood pressure, fasting glucose, triglycerides, and high-density lipoproteins.

Results: Compared to those with normal glucose tolerance, visceral fat and IR were higher and β-cell function was lower in adults with glucose intolerance and type 2 diabetes mellitus. Elevated visceral fat and IR (HOMA-IR and Matsuda Index) correlated with elevated Z-scores (r=0.51, r=0.54, r=-0.49; all P<0.002, respectively). Basal, first-, and second-phase β-cell function correlated with low Z-scores (r=-0.59, r=-0.51, and r=-0.43, all P<0.001). Insulin secretion significantly predicted the Z-score independent of sex, body fat, blood lipids, blood pressure, IR, and glucose metabolism (P<0.005).

Conclusion: β-cell dysfunction is highly correlated with the severity of metabolic syndrome in adults. Future work is warranted to elucidate the mechanism by which cardiometabolic disturbances influence insulin secretion.

Citing Articles

-Aminoisobutyric Acid Relates to Favorable Glucose Metabolism through Adiponectin in Adults with Obesity Independent of Prediabetes.

Faiz H, Heiston E, Malin S J Diabetes Res. 2023; 2023:4618215.

PMID: 37780967 PMC: 10539091. DOI: 10.1155/2023/4618215.


The Values and Perspectives of Organoids in the Field of Metabolic Syndrome.

Tan C, Ding M, Zheng Y Int J Mol Sci. 2023; 24(9).

PMID: 37175830 PMC: 10179392. DOI: 10.3390/ijms24098125.


Relationship and Effects of Vitamin D on Metabolic Syndrome: A Systematic Review.

Theik N, Raji O, Shenwai P, Shah R, Kalluri S, Bhutta T Cureus. 2021; 13(8):e17419.

PMID: 34589329 PMC: 8460559. DOI: 10.7759/cureus.17419.


Insulin stimulation reduces aortic wave reflection in adults with metabolic syndrome.

Dotson B, Heiston E, Miller S, Malin S Am J Physiol Heart Circ Physiol. 2021; 320(6):H2305-H2312.

PMID: 33861146 PMC: 8289357. DOI: 10.1152/ajpheart.00975.2020.


Cannabinoid receptors are differentially regulated in the pancreatic islets during the early development of metabolic syndrome.

Barajas-Martinez A, Bermeo K, De la Cruz L, Martinez-Vargas M, Martinez-Tapia R, Garcia D Islets. 2020; 12(6):134-144.

PMID: 33289595 PMC: 7751681. DOI: 10.1080/19382014.2020.1849927.


References
1.
Cobelli C, Toffolo G, Dalla Man C, Campioni M, Denti P, Caumo A . Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab. 2007; 293(1):E1-E15. DOI: 10.1152/ajpendo.00421.2006. View

2.
Ford E . Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005; 28(11):2745-9. DOI: 10.2337/diacare.28.11.2745. View

3.
Perreault L, Kahn S, Christophi C, Knowler W, Hamman R . Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care. 2009; 32(9):1583-8. PMC: 2732165. DOI: 10.2337/dc09-0523. View

4.
Kahn S, Prigeon R, McCulloch D, Boyko E, Bergman R, Schwartz M . Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993; 42(11):1663-72. DOI: 10.2337/diab.42.11.1663. View

5.
Muzumdar R, Ma X, Atzmon G, Vuguin P, Yang X, Barzilai N . Decrease in glucose-stimulated insulin secretion with aging is independent of insulin action. Diabetes. 2004; 53(2):441-6. DOI: 10.2337/diabetes.53.2.441. View